RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Peptides After Peptide Sciences Renew Vitality The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review